Julius Upmeier zu Belzen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Julius Upmeier zu Belzen has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Roland Eils
Digital Health Center, Berlin Institute of Health (BIH) and Charité University Medicine, Berlin, Germany
12 shared publications - Benjamin Wild
Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany
9 shared publications - Thore Buergel
Synthetic Biology Group, Institute for Pharmacy and Molecular Biotechnology and Center for Quantitative Analysis of Molecular and Cellular Biosystems, University of Heidelberg, Heidelberg, Germany
6 shared publications - Claudia Langenberg
Computational Medicine, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
5 shared publications John Deanfield
Institute of Cardiovascular Sciences, University College London, London, UK
5 shared publications- Maik Pietzner
Computational Medicine, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
5 shared publications
Latest Publications
- Open Access
An interpretable omnigenic neural network architecture for the human genome
Genetic prediction of complex phenotypes typically relies on additive linear models, which scale well but cannot capture non-additive effects or deeply integrate molecular and clinical data. Domain-specific neural networks have driven advances in images, text, and other modalities, but genome-scale neural networks remain challenging because genotypes are sparse and high-dimensional, effective sample sizes are limited, and generic architectures lack interpretability. Here, we introduce the omnigenic neural network, a biologically structured architecture inspired by the omnigenic model of complex traits. The model learns hierarchical representations of biological processes, accommodates multimodal inputs, supports transfer learning, and enables multitask prediction. Models trained in the UK Biobank and evaluated in the All of Us cohort for ischemic heart disease, type 2 diabetes, and schizophrenia outperformed published PGS Catalog and PRS-CSx scores. A multitask model trained across 36 cardiovascular endpoints further outperformed corresponding single-phenotype models and baselines. The architecture provides systems-level interpretability by quantifying the contributions of biological processes, which were consistent with established disease mechanisms. It also captures non-linear interactions between variants. Analysis of these interactions using Integrated Hessians revealed patterns concordant with previously reported epistatic associations. Together, these findings establish the omnigenic neural network as a flexible framework for interpretable, multimodal, and multitask genomic prediction.
Open AccessAn interpretable omnigenic neural network architecture for the human genome
Genetic prediction of complex phenotypes typically relies on additive linear models, which scale well but cannot capture non-additive effects or deeply integrate molecular and clinical data. Domain-specific neural networks have driven advances in images, text, and other modalities, but genome-scale neural networks remain challenging because genotypes are sparse and high-dimensional, effective sample sizes are limited, and generic architectures lack interpretability. Here, we introduce the omnigenic neural network, a biologically structured architecture inspired by the omnigenic model of complex traits. The model learns hierarchical representations of biological processes, accommodates multimodal inputs, supports transfer learning, and enables multitask prediction. Models trained in the UK Biobank and evaluated in the All of Us cohort for ischemic heart disease, type 2 diabetes, and schizophrenia outperformed published PGS Catalog and PRS-CSx scores. A multitask model trained across 36 cardiovascular endpoints further outperformed corresponding single-phenotype models and baselines. The architecture provides systems-level interpretability by quantifying the contributions of biological processes, which were consistent with established disease mechanisms. It also captures non-linear interactions between variants. Analysis of these interactions using Integrated Hessians revealed patterns concordant with previously reported epistatic associations. Together, these findings establish the omnigenic neural network as a flexible framework for interpretable, multimodal, and multitask genomic prediction.
- Open Access
- 19 March 2026
- Published by Elsevier in The Lancet Digital Health
- Vol. 8 (3) , 100962
A predictive atlas of disease onset from retinal fundus photographs: a modelling study using data from population-based cohorts
- 19 March 2026
- Published by Elsevier in The Lancet Digital Health
- Vol. 8 (3) , 100962
Open AccessA predictive atlas of disease onset from retinal fundus photographs: a modelling study using data from population-based cohorts
- Open Access
Biologically Guided Variational Inference for Interpretable Multimodal Single-Cell Integration and Mechanistic Discovery
Multi-omics technologies allow for a detailed characterization of cell types and states across multiple omics layers, helping to identify features that differentiate biological conditions, such as chemical or CRISPR-based perturbations. However, current tools employing variational inference on single-cell datasets, including methods for paired and mosaic integration, transfer learning, and modality imputation, typically act as black boxes. This lack of interpretability makes it challenging to evaluate whether biological variation is preserved, which can compromise downstream analyses. Here, we introduce NetworkVI, a sparse deep generative model designed for the integration and interpretation of multimodal single-cell data. NetworkVI utilizes biological prior knowledge as an inductive bias, specifically it relies on gene-gene interactions inferred from topologically associated domains and structured ontologies like the Gene Ontology to aggregate gene embeddings to cell embeddings, enhancing the interpretability at the gene and subcellular level. While achieving state-of-the-art data integration, modality imputation, and cell label transfer via query-to-reference mapping benchmarks across bimodal and trimodal datasets, NetworkVI additionally excels in providing biologically meaningful modality- and cell type-specific interpretations. NetworkVI aids researchers in identifying associations between genes and biological processes and uncovers immune evasion mechanisms in a Perturb CITE-seq dataset of melanoma cells. NetworkVI will support researchers in interpreting cellular disease mechanisms, guiding biomarker discovery, and ultimately aiding the development of targeted therapies in large-scale single-cell multimodal atlases. NetworkVI is available at http://github.com/LArnoldt/networkVI .
Open AccessBiologically Guided Variational Inference for Interpretable Multimodal Single-Cell Integration and Mechanistic Discovery
Multi-omics technologies allow for a detailed characterization of cell types and states across multiple omics layers, helping to identify features that differentiate biological conditions, such as chemical or CRISPR-based perturbations. However, current tools employing variational inference on single-cell datasets, including methods for paired and mosaic integration, transfer learning, and modality imputation, typically act as black boxes. This lack of interpretability makes it challenging to evaluate whether biological variation is preserved, which can compromise downstream analyses. Here, we introduce NetworkVI, a sparse deep generative model designed for the integration and interpretation of multimodal single-cell data. NetworkVI utilizes biological prior knowledge as an inductive bias, specifically it relies on gene-gene interactions inferred from topologically associated domains and structured ontologies like the Gene Ontology to aggregate gene embeddings to cell embeddings, enhancing the interpretability at the gene and subcellular level. While achieving state-of-the-art data integration, modality imputation, and cell label transfer via query-to-reference mapping benchmarks across bimodal and trimodal datasets, NetworkVI additionally excels in providing biologically meaningful modality- and cell type-specific interpretations. NetworkVI aids researchers in identifying associations between genes and biological processes and uncovers immune evasion mechanisms in a Perturb CITE-seq dataset of melanoma cells. NetworkVI will support researchers in interpreting cellular disease mechanisms, guiding biomarker discovery, and ultimately aiding the development of targeted therapies in large-scale single-cell multimodal atlases. NetworkVI is available at http://github.com/LArnoldt/networkVI .
- Open Access
- 10 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Author Correction: Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
- 10 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Open AccessAuthor Correction: Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
- RetractedOpen Access
- 10 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
The COVID-19 pandemic exposed a global deficiency of systematic, data-driven guidance to identify high-risk individuals. Here, we illustrate the utility of routinely recorded medical history to predict the risk for 1741 diseases across clinical specialties and support the rapid response to emerging health threats such as COVID-19. We developed a neural network to learn from health records of 502,489 UK Biobank participants. Importantly, we observed discriminative improvements over basic demographic predictors for 1546 (88.8%) endpoints. After transferring the unmodified risk models to the All of US cohort, we replicated these improvements for 1115 (78.9%) of 1414 investigated endpoints, demonstrating generalizability across healthcare systems and historically underrepresented groups. Ultimately, we showed how this approach could have been used to identify individuals vulnerable to severe COVID-19. Our study demonstrates the potential of medical history to support guidance for emerging pandemics by systematically estimating risk for thousands of diseases at once at minimal cost.
- 10 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
RetractedOpen AccessMedical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
The COVID-19 pandemic exposed a global deficiency of systematic, data-driven guidance to identify high-risk individuals. Here, we illustrate the utility of routinely recorded medical history to predict the risk for 1741 diseases across clinical specialties and support the rapid response to emerging health threats such as COVID-19. We developed a neural network to learn from health records of 502,489 UK Biobank participants. Importantly, we observed discriminative improvements over basic demographic predictors for 1546 (88.8%) endpoints. After transferring the unmodified risk models to the All of US cohort, we replicated these improvements for 1115 (78.9%) of 1414 investigated endpoints, demonstrating generalizability across healthcare systems and historically underrepresented groups. Ultimately, we showed how this approach could have been used to identify individuals vulnerable to severe COVID-19. Our study demonstrates the potential of medical history to support guidance for emerging pandemics by systematically estimating risk for thousands of diseases at once at minimal cost.
- Open Access
- 12 September 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (11) , 3369-3380
An open-source framework for end-to-end analysis of electronic health record data
With progressive digitalization of healthcare systems worldwide, large-scale collection of electronic health records (EHRs) has become commonplace. However, an extensible framework for comprehensive exploratory analysis that accounts for data heterogeneity is missing. Here we introduce ehrapy, a modular open-source Python framework designed for exploratory analysis of heterogeneous epidemiology and EHR data. ehrapy incorporates a series of analytical steps, from data extraction and quality control to the generation of low-dimensional representations. Complemented by rich statistical modules, ehrapy facilitates associating patients with disease states, differential comparison between patient clusters, survival analysis, trajectory inference, causal inference and more. Leveraging ontologies, ehrapy further enables data sharing and training EHR deep learning models, paving the way for foundational models in biomedical research. We demonstrate ehrapy’s features in six distinct examples. We applied ehrapy to stratify patients affected by unspecified pneumonia into finer-grained phenotypes. Furthermore, we reveal biomarkers for significant differences in survival among these groups. Additionally, we quantify medication-class effects of pneumonia medications on length of stay. We further leveraged ehrapy to analyze cardiovascular risks across different data modalities. We reconstructed disease state trajectories in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on imaging data. Finally, we conducted a case study to demonstrate how ehrapy can detect and mitigate biases in EHR data. ehrapy, thus, provides a framework that we envision will standardize analysis pipelines on EHR data and serve as a cornerstone for the community.
- 12 September 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (11) , 3369-3380
Open AccessAn open-source framework for end-to-end analysis of electronic health record data
With progressive digitalization of healthcare systems worldwide, large-scale collection of electronic health records (EHRs) has become commonplace. However, an extensible framework for comprehensive exploratory analysis that accounts for data heterogeneity is missing. Here we introduce ehrapy, a modular open-source Python framework designed for exploratory analysis of heterogeneous epidemiology and EHR data. ehrapy incorporates a series of analytical steps, from data extraction and quality control to the generation of low-dimensional representations. Complemented by rich statistical modules, ehrapy facilitates associating patients with disease states, differential comparison between patient clusters, survival analysis, trajectory inference, causal inference and more. Leveraging ontologies, ehrapy further enables data sharing and training EHR deep learning models, paving the way for foundational models in biomedical research. We demonstrate ehrapy’s features in six distinct examples. We applied ehrapy to stratify patients affected by unspecified pneumonia into finer-grained phenotypes. Furthermore, we reveal biomarkers for significant differences in survival among these groups. Additionally, we quantify medication-class effects of pneumonia medications on length of stay. We further leveraged ehrapy to analyze cardiovascular risks across different data modalities. We reconstructed disease state trajectories in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on imaging data. Finally, we conducted a case study to demonstrate how ehrapy can detect and mitigate biases in EHR data. ehrapy, thus, provides a framework that we envision will standardize analysis pipelines on EHR data and serve as a cornerstone for the community.
- RetractionOpen Access
- 20 May 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
RETRACTED ARTICLE: Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
The COVID-19 pandemic exposed a global deficiency of systematic, data-driven guidance to identify high-risk individuals. Here, we illustrate the utility of routinely recorded medical history to predict the risk for 1883 diseases across clinical specialties and support the rapid response to emerging health threats such as COVID-19. We developed a neural network to learn from health records of 502,460 UK Biobank. Importantly, we observed discriminative improvements over basic demographic predictors for 1774 (94.3%) endpoints. After transferring the unmodified risk models to the All of US cohort, we replicated these improvements for 1347 (89.8%) of 1500 investigated endpoints, demonstrating generalizability across healthcare systems and historically underrepresented groups. Ultimately, we showed how this approach could have been used to identify individuals vulnerable to severe COVID-19. Our study demonstrates the potential of medical history to support guidance for emerging pandemics by systematically estimating risk for thousands of diseases at once at minimal cost.
- 20 May 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
RetractionOpen AccessRETRACTED ARTICLE: Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
The COVID-19 pandemic exposed a global deficiency of systematic, data-driven guidance to identify high-risk individuals. Here, we illustrate the utility of routinely recorded medical history to predict the risk for 1883 diseases across clinical specialties and support the rapid response to emerging health threats such as COVID-19. We developed a neural network to learn from health records of 502,460 UK Biobank. Importantly, we observed discriminative improvements over basic demographic predictors for 1774 (94.3%) endpoints. After transferring the unmodified risk models to the All of US cohort, we replicated these improvements for 1347 (89.8%) of 1500 investigated endpoints, demonstrating generalizability across healthcare systems and historically underrepresented groups. Ultimately, we showed how this approach could have been used to identify individuals vulnerable to severe COVID-19. Our study demonstrates the potential of medical history to support guidance for emerging pandemics by systematically estimating risk for thousands of diseases at once at minimal cost.
- Open Access
A predictive atlas of disease onset from retinal fundus photographs
Early detection of high-risk individuals is crucial for healthcare systems to cope with changing demographics and an ever-increasing patient population. Images of the retinal fundus are a non-invasive, low-cost examination routinely collected and potentially scalable beyond ophthalmology. Prior work demonstrated the potential of retinal images for risk assessment for common cardiometabolic diseases, but it remains unclear whether this potential extends to a broader range of human diseases. Here, we extended a retinal foundation model (RETFound) to systematically explore the predictive potential of retinal images as a low-cost screening strategy for disease onset across >750 incident diseases in >60,000 individuals. For more than a third (n=308) of the diseases, we demonstrated improved discriminative performance compared to readily available patient characteristics. This included 281 diseases outside of ophthalmology, such as type 2 diabetes (Delta C-Index: UK Biobank +0.073 (0.068, 0.079)) or chronic obstructive pulmonary disease (Delta C-Index: UK Biobank +0.047 (0.039, 0.054)), showcasing the potential of retinal images to complement screening strategies more widely. Moreover, we externally validated these findings in 7,248 individuals from the EPIC-Norfolk Eye Study. Notably, retinal information did not improve the prediction for the onset of cardiovascular diseases compared to established primary prevention scores, demonstrating the need for rigorous benchmarking and disease-agnostic efforts to design cost-efficient screening strategies to improve population health. We demonstrated that predictive improvements were attributable to retinal vascularisation patterns and less obvious features, such as eye colour or lens morphology, by extracting image attributions from risk models and performing genome-wide association studies, respectively. Genetic findings further highlighted commonalities between eye-derived risk estimates and complex disorders, including novel loci, such as IMAP1 , for iron homeostasis. In conclusion, we present the first comprehensive evaluation of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of easily accessible and low-cost retinal images for risk assessment across common and rare diseases. Research in context: Evidence before this study: Before undertaking this study, we reviewed the literature on the predictive utility of medical imaging for disease onset, focusing particularly on retinal fundus photographs. We conducted searches in databases including PubMed and Google Scholar, spanning from the inception of these databases to January 1, 2023. Our search terms included “retinal fundus photography”, “disease prediction”, “machine learning”, “deep learning”, and “healthcare AI”, without language restrictions. Prior research has shown the promise of retinal images in diagnosing and predicting a range of conditions, notably within ophthalmology and specific systemic diseases such as diabetes and cardiovascular diseases. However, a comprehensive evaluation of retinal images’ predictive potential across a broad spectrum of diseases, particularly those without known associations to retinal changes, was lacking. Studies identified varied in quality, with many focusing on single diseases or small datasets, indicating a potential risk of bias and overfitting. Added value of this study: Our study extends the application of retinal fundus photographs from ophthalmological and systemic diseases to more than 750 incident diseases, leveraging a foundation model combined with a deep multi-task neural network. This represents the first systematic exploration of the predictive potential of retinal images across the human phenome, significantly expanding the scope of diseases for which these images could serve as a low-cost screening strategy. Moreover, we rigorously compare the predictive value of retinal images against established primary prevention scores for cardiovascular diseases, showing both the strengths and limitations of this approach. This dual focus provides a nuanced understanding of where retinal imaging can complement existing screening strategies and where it may not offer additional predictive value. Implications of all the available evidence: The evidence from our study, combined with existing research, suggests that retinal fundus photographs hold promise for predicting disease onset across a wide range of conditions, far beyond their current use. However, our work also emphasizes the importance of contextualizing these findings within the broader landscape of available prediction tools and established primary prevention. The implications for practice include the potential integration of retinal imaging into broader screening programs, particularly for diseases where predictive gains over existing methods are demonstrated. For policy, our findings advocate for further investment in AI and machine learning research in healthcare, particularly in methods that improve upon or complement existing prediction models. Future research should focus on refining these predictive models, exploring the integration of retinal imaging with other biomarkers, and conducting prospective studies to validate the clinical utility of these approaches in diverse populations.
Open AccessA predictive atlas of disease onset from retinal fundus photographs
Early detection of high-risk individuals is crucial for healthcare systems to cope with changing demographics and an ever-increasing patient population. Images of the retinal fundus are a non-invasive, low-cost examination routinely collected and potentially scalable beyond ophthalmology. Prior work demonstrated the potential of retinal images for risk assessment for common cardiometabolic diseases, but it remains unclear whether this potential extends to a broader range of human diseases. Here, we extended a retinal foundation model (RETFound) to systematically explore the predictive potential of retinal images as a low-cost screening strategy for disease onset across >750 incident diseases in >60,000 individuals. For more than a third (n=308) of the diseases, we demonstrated improved discriminative performance compared to readily available patient characteristics. This included 281 diseases outside of ophthalmology, such as type 2 diabetes (Delta C-Index: UK Biobank +0.073 (0.068, 0.079)) or chronic obstructive pulmonary disease (Delta C-Index: UK Biobank +0.047 (0.039, 0.054)), showcasing the potential of retinal images to complement screening strategies more widely. Moreover, we externally validated these findings in 7,248 individuals from the EPIC-Norfolk Eye Study. Notably, retinal information did not improve the prediction for the onset of cardiovascular diseases compared to established primary prevention scores, demonstrating the need for rigorous benchmarking and disease-agnostic efforts to design cost-efficient screening strategies to improve population health. We demonstrated that predictive improvements were attributable to retinal vascularisation patterns and less obvious features, such as eye colour or lens morphology, by extracting image attributions from risk models and performing genome-wide association studies, respectively. Genetic findings further highlighted commonalities between eye-derived risk estimates and complex disorders, including novel loci, such as IMAP1 , for iron homeostasis. In conclusion, we present the first comprehensive evaluation of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of easily accessible and low-cost retinal images for risk assessment across common and rare diseases. Research in context: Evidence before this study: Before undertaking this study, we reviewed the literature on the predictive utility of medical imaging for disease onset, focusing particularly on retinal fundus photographs. We conducted searches in databases including PubMed and Google Scholar, spanning from the inception of these databases to January 1, 2023. Our search terms included “retinal fundus photography”, “disease prediction”, “machine learning”, “deep learning”, and “healthcare AI”, without language restrictions. Prior research has shown the promise of retinal images in diagnosing and predicting a range of conditions, notably within ophthalmology and specific systemic diseases such as diabetes and cardiovascular diseases. However, a comprehensive evaluation of retinal images’ predictive potential across a broad spectrum of diseases, particularly those without known associations to retinal changes, was lacking. Studies identified varied in quality, with many focusing on single diseases or small datasets, indicating a potential risk of bias and overfitting. Added value of this study: Our study extends the application of retinal fundus photographs from ophthalmological and systemic diseases to more than 750 incident diseases, leveraging a foundation model combined with a deep multi-task neural network. This represents the first systematic exploration of the predictive potential of retinal images across the human phenome, significantly expanding the scope of diseases for which these images could serve as a low-cost screening strategy. Moreover, we rigorously compare the predictive value of retinal images against established primary prevention scores for cardiovascular diseases, showing both the strengths and limitations of this approach. This dual focus provides a nuanced understanding of where retinal imaging can complement existing screening strategies and where it may not offer additional predictive value. Implications of all the available evidence: The evidence from our study, combined with existing research, suggests that retinal fundus photographs hold promise for predicting disease onset across a wide range of conditions, far beyond their current use. However, our work also emphasizes the importance of contextualizing these findings within the broader landscape of available prediction tools and established primary prevention. The implications for practice include the potential integration of retinal imaging into broader screening programs, particularly for diseases where predictive gains over existing methods are demonstrated. For policy, our findings advocate for further investment in AI and machine learning research in healthcare, particularly in methods that improve upon or complement existing prediction models. Future research should focus on refining these predictive models, exploring the integration of retinal imaging with other biomarkers, and conducting prospective studies to validate the clinical utility of these approaches in diverse populations.
- Open Access
Exploratory electronic health record analysis with ehrapy
With progressive digitalization of healthcare systems worldwide, large-scale collection of electronic health records (EHRs) has become commonplace. However, an extensible framework for comprehensive exploratory analysis that accounts for data heterogeneity is missing. Here, we introduce ehrapy, a modular open-source Python framework designed for exploratory end-to-end analysis of heterogeneous epidemiology and electronic health record data. Ehrapy incorporates a series of analytical steps, from data extraction and quality control to the generation of low-dimensional representations. Complemented by rich statistical modules, ehrapy facilitates associating patients with disease states, differential comparison between patient clusters, survival analysis, trajectory inference, causal inference, and more. Leveraging ontologies, ehrapy further enables data sharing and training EHR deep learning models paving the way for foundational models in biomedical research. We demonstrated ehrapy’s features in five distinct examples: We first applied ehrapy to stratify patients affected by unspecified pneumonia into finer-grained phenotypes. Furthermore, we revealed biomarkers for significant differences in survival among these groups. Additionally, we quantify medication-class effects of pneumonia medications on length of stay. We further leveraged ehrapy to analyze cardiovascular risks across different data modalities. Finally, we reconstructed disease state trajectories in SARS-CoV-2 patients based on imaging data. Ehrapy thus provides a framework that we envision will standardize analysis pipelines on EHR data and serve as a cornerstone for the community.
Open AccessExploratory electronic health record analysis with ehrapy
With progressive digitalization of healthcare systems worldwide, large-scale collection of electronic health records (EHRs) has become commonplace. However, an extensible framework for comprehensive exploratory analysis that accounts for data heterogeneity is missing. Here, we introduce ehrapy, a modular open-source Python framework designed for exploratory end-to-end analysis of heterogeneous epidemiology and electronic health record data. Ehrapy incorporates a series of analytical steps, from data extraction and quality control to the generation of low-dimensional representations. Complemented by rich statistical modules, ehrapy facilitates associating patients with disease states, differential comparison between patient clusters, survival analysis, trajectory inference, causal inference, and more. Leveraging ontologies, ehrapy further enables data sharing and training EHR deep learning models paving the way for foundational models in biomedical research. We demonstrated ehrapy’s features in five distinct examples: We first applied ehrapy to stratify patients affected by unspecified pneumonia into finer-grained phenotypes. Furthermore, we revealed biomarkers for significant differences in survival among these groups. Additionally, we quantify medication-class effects of pneumonia medications on length of stay. We further leveraged ehrapy to analyze cardiovascular risks across different data modalities. Finally, we reconstructed disease state trajectories in SARS-CoV-2 patients based on imaging data. Ehrapy thus provides a framework that we envision will standardize analysis pipelines on EHR data and serve as a cornerstone for the community.
- Open Access
Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
The COVID-19 pandemic exposed, with few exceptions, a global deficiency in delivering systematic, data-driven guidance to protect citizens and coordinate vaccination programs. At the same time, medical histories are routinely recorded in most healthcare systems and are instantly available for risk assessment. Here, we demonstrate the utility of medical history in determining the risk for 1,883 diseases across clinical specialties and facilitating the rapid response to emerging health threats at the example of COVID-19. We developed a neural network to learn disease-specific risk states from routinely collected health records of 502,460 UK Biobank participants, demonstrating risk stratification for nearly all conditions, and validated this model on 229,830 individuals from the All of US cohort. When integrated into Cox Proportional Hazard Models, we observed significant discriminative improvements over basic demographic predictors for 1,774 (94.3%). After transferring the unmodified risk models to the All of US cohort, the discriminate improvements were replicated for 1,347 (89.8%) of 1,500 investigated endpoints, demonstrating model generalizability across healthcare systems and historically underrepresented groups. We then show that these risk states can be used to identify individuals vulnerable to severe COVID-19 and mortality. Our study demonstrates the currently underused potential of medical history to rapidly respond to emerging health threats by systematically estimating risk for thousands of diseases at once at minimal cost.
Open AccessMedical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
The COVID-19 pandemic exposed, with few exceptions, a global deficiency in delivering systematic, data-driven guidance to protect citizens and coordinate vaccination programs. At the same time, medical histories are routinely recorded in most healthcare systems and are instantly available for risk assessment. Here, we demonstrate the utility of medical history in determining the risk for 1,883 diseases across clinical specialties and facilitating the rapid response to emerging health threats at the example of COVID-19. We developed a neural network to learn disease-specific risk states from routinely collected health records of 502,460 UK Biobank participants, demonstrating risk stratification for nearly all conditions, and validated this model on 229,830 individuals from the All of US cohort. When integrated into Cox Proportional Hazard Models, we observed significant discriminative improvements over basic demographic predictors for 1,774 (94.3%). After transferring the unmodified risk models to the All of US cohort, the discriminate improvements were replicated for 1,347 (89.8%) of 1,500 investigated endpoints, demonstrating model generalizability across healthcare systems and historically underrepresented groups. We then show that these risk states can be used to identify individuals vulnerable to severe COVID-19 and mortality. Our study demonstrates the currently underused potential of medical history to rapidly respond to emerging health threats by systematically estimating risk for thousands of diseases at once at minimal cost.